Ventricular remodeling

Revision as of 17:20, 20 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
Jump to navigation Jump to search

WikiDoc Resources for Ventricular remodeling

Articles

Most recent articles on Ventricular remodeling

Most cited articles on Ventricular remodeling

Review articles on Ventricular remodeling

Articles on Ventricular remodeling in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ventricular remodeling

Images of Ventricular remodeling

Photos of Ventricular remodeling

Podcasts & MP3s on Ventricular remodeling

Videos on Ventricular remodeling

Evidence Based Medicine

Cochrane Collaboration on Ventricular remodeling

Bandolier on Ventricular remodeling

TRIP on Ventricular remodeling

Clinical Trials

Ongoing Trials on Ventricular remodeling at Clinical Trials.gov

Trial results on Ventricular remodeling

Clinical Trials on Ventricular remodeling at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ventricular remodeling

NICE Guidance on Ventricular remodeling

NHS PRODIGY Guidance

FDA on Ventricular remodeling

CDC on Ventricular remodeling

Books

Books on Ventricular remodeling

News

Ventricular remodeling in the news

Be alerted to news on Ventricular remodeling

News trends on Ventricular remodeling

Commentary

Blogs on Ventricular remodeling

Definitions

Definitions of Ventricular remodeling

Patient Resources / Community

Patient resources on Ventricular remodeling

Discussion groups on Ventricular remodeling

Patient Handouts on Ventricular remodeling

Directions to Hospitals Treating Ventricular remodeling

Risk calculators and risk factors for Ventricular remodeling

Healthcare Provider Resources

Symptoms of Ventricular remodeling

Causes & Risk Factors for Ventricular remodeling

Diagnostic studies for Ventricular remodeling

Treatment of Ventricular remodeling

Continuing Medical Education (CME)

CME Programs on Ventricular remodeling

International

Ventricular remodeling en Espanol

Ventricular remodeling en Francais

Business

Ventricular remodeling in the Marketplace

Patents on Ventricular remodeling

Experimental / Informatics

List of terms related to Ventricular remodeling

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and Keywords: left ventricular remodeling, LV remodeling

Overview

Ventricular remodeling refers to the changes in size, shape, and function of the heart after injury to the left ventricle. The injury is typically due to acute myocardial infarction (usually transmural or ST segment elevation infarction), but may be from a number of causes that result in increased pressure or volume overload (forms of strain) on the heart. Chronic hypertension, congenital heart disease with intracardiac shunting, and valvular heart disease may also lead to remodeling. After the insult occurs, a series of histopathological and structural changes occur in the left ventricular myocardium that lead to progressive decline in left ventricular performance. Ultimately, ventricular remodeling may result in diminished contractile (systolic) function and reduced stroke volume.

Medically speaking, "ventricular remodeling" implies a decline in function (even though the word "remodeling" usually implies improvement). The term "reverse remodeling" in cardiology implies an improvement in ventricular mechanics and function after a remote injury.

Pathophysiology

The cardiac myocyte is the major cell involved in remodeling. Fibroblasts, collagen, the interstitium, and the coronary vessels to a lesser extent, also play a role. A common scenario for remodeling is after myocardial infarction. There is myocardial necrosis (cell death) and disproportionate thinning of the heart. This thin, weakened area is unable to withstand the pressure and volume load on the heart in the same manner as the other healthy tissue. As a result there is dilatation of the chamber arising from the infarct region. The initial remodeling phase after a myocardial infarction results in repair of the necrotic area and scar formation that may, to some extent, be considered beneficial since there is an improvement in or maintenance of LV function and cardiac output. Over time, however, as the heart undergoes ongoing remodeling, it becomes less elliptical and more spherical. Ventricular mass and volume increase, which together adversely affect cardiac function. Eventually, diastolic function, or the heart's ability to relax between contractions may become impaired, further causing decline.

Treatment

Many factors influence the time course and extent of remodeling, including the severity of the insult, secondary events (recurrent ischemia or infarction), neurohormonal activation, genetic factors and gene expression, and treatment. Medications may attenuate remodeling. Angiotensin-converting enzyme (ACE) inhibitors have been consistently shown to decrease remodeling in animal models or transmural infarction and chronic pressure overload. Clinical trials have shown that ACE inhibitor therapy after myocardial infarction leads to improved myocardial performance, improved ejection fraction, and decreased mortality compared to patients treated with placebo. Early correction of congenital heart defects, if appropriate, may prevent remodeling, as will treatment of chronic hypertension or valvular heart disease. Often, reverse remodeling, or improvement in left ventricular function, will also be seen.

Related chapters

References

  • Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000 Mar 1;35(3):569-82.
  • Sutton, MG, Sharpe, N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000; 101:2981
  • Konstam, MA, Kronenberg, MW, Rousseau, MF, et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Circulation 1993; 88:2277.
  • Greenberg, B, Quinones, MA, Koilpillai, C, et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation 1995; 91:2573.
  • Doughty, RN, Whalley, GA, Gamble, G, et al. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol 1997; 29:1060.
  • Cohn JN. Cardiac Remodeling, UpToDate v.13.1 www.uptodateonline.com. Accessed July 17, 2005.


Template:WikiDoc Sources